Trastuzumab emtansine (T-DM1) plus capecitabine (X) in patients with HER2-positive MBC: MO28230 TRAX-HER2 phase 1 results.Karen A. Gelmon, Véronique Dièras, Marie‐Paule Sablin et al.|Journal of Clinical Oncology|2014Cited by 4